Tranexamic Acid
Product Images NDC 63323-563

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 63323-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tra12 0002 01

Chemical structure of Tranexamic Acid showing a cyclohexane ring with an amino group (NH2) and a carboxylic acid functional group (COOH) attached.*

FDA Label Image

Tra12 0002 02

FDA Label Image

Tra12 0002 03

Label of Tranexamic Acid Injection, USP 1,000 mg/10 mL (100 mg/mL) single-dose vial by Fresenius Kabi USA, LLC. The label indicates intravenous use only and details that each mL contains 100 mg of active tranexamic acid. It states to discard unused portions and that the container closure is latex-free.*

FDA Label Image

Tra12 0002 04

Tranexamic Acid Injection, USP 1,000 mg/10 mL (100 mg/mL) label from Fresenius Kabi USA, LLC. The label indicates intravenous use only, contains 10 single-dose vials of 10 mL each. It specifies active ingredient concentration, storage conditions (20°C to 25°C with permitted excursions), and notes the container closure is latex-free.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.